AMA Journal of Ethics

Ethics Talk: How to Change Organizational Culture

What should clinicians do to change organizational cultures that negatively influence care they can deliver to patients? This month on Ethics Talk, Tara Montgomery and Dr Zackary Berger discuss how to identify and respond to health care organizational cultural influences…

Ethics Talk: How Can Decision Science Help Navigate Complex Health Decisions?

Decision making in health care demands that we balance multiple considerations, like quality of life, statistics, and how different options could affect others. Dr Brian Zikmund-Fisher shares his own experience as a patient and explains how decision science can help…

Ethics Talk: Ebola Responses in Colonial Context

Good epidemic responses require cross-disciplinary collaboration. Dr David Heymann talks about serving in an Ebola containment campaign and Dr Christy Rentmeester explains what clinicians should know about colonialism to promote health equity.

Ethics Talk: How Do We Prepare for Human Gene Editing?

How should we prepare for rapid advancement of gene editing technology? This month on Ethics Talk, Dr Sean C. McConnell provides an introduction to gene editing and CRISPR technology and Scott J. Schweikart discusses what prudent governance requires.

Ethics Talk: Quality of Life Assessments in Reconstructive Transplantation

In reconstructive transplantation, quality of life assessments incorporate many variables. Dr Katrina Bramstedt and Dr Ana Iltis discuss the development of QoL assessment tools to help patient-subjects considering reconstructive transplantation.

Ethics Talk: Providing Compassionate Care for Transmen

In this episode, transgender advocate and author Ryan Sallans discusses his experience accessing health care as a transman and offers a guide for caring well for anyone with a cervix.

Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?

Implantable brain-computer interface (BCI) and other devices with potential for both therapeutic purposes and human enhancement are being rapidly developed. The distinction between therapeutic and enhancement uses of these devices is not well defined. While the US Food and Drug…

Is the FDA Failing Women?

Many devices in current use were marketed before the US Food and Drug Administration (FDA) began regulating devices in 1976. Thus, manufacturers of these devices were not required to demonstrate safety and effectiveness, which presents both clinical and ethical problem…